The Pfizer vacuum cleaner does not require ultra-free heating: it can be heated to a temperature of between -25 and -15 degrees

Pfizer y BioNTech announce this year the presentation of new dates to the Food and Drug Administration of the United States (FDA, by his seals in English) which demonstrate the stability of its vaccine against the coronavirus when released during two weeks at a temperature of between -25 ° C and -15 ° C, the most habitable in the drug collectors and refrigerators.

It will serve as an alternative to supplementation with an ultra-low temperature condenser. Currently, the evacuation technique sheet is established which must be placed on a congelador ultra-free and temperature within -80ºC and -60ºC for a period of up to 6 months.

The vacancies are sent to a thermal container specially designed by Pfizer which can be used as temporary maintenance for a total of up to 30 days with hello every two days. It generates logistical problems for its transportation to the zones of the world with only preparation for these circumstances, such as Africa.

Antes de mezclarse con un un diluyente salino, la vacuna también puede refrigerede durante un maximo de cinco días a la tempera standar de frigorífico, entre 2 ° C y 8 ​​° C. Posteriormente, la vacuna es administrada a tempera ambiente por los enfermeros.

If approved, the cooling option at a temperature of -25 ° C to -15 ° C during the weeks will be summarized in this option for five days of cooling to the temperature of the refrigerator. The insurance companies that present these dates to the rest of the global regulatory agencies “in close proximity”.

‘If approved, it would be a new option to open the hospital to pharmacies and evacuation centers, allowing a mayor to have the flexibility to manage his vacancy manager. We are constantly conducting stability studies to support the production of the commercial-scale vaccine, with the aim of making the vaccine the most accessible possible in the world “, commented on the President and CEO of Pfizer, Albert Bourla.

‘Our maximum priority is to quickly unlock a safe and effective vaccine and provide the most vulnerable people in the world to save lives. At the same time, we continuously collect dates that can allow the emergency to reach -20 ° C. The dates presented can facilitate the management of our vacancies in the pharmacies and proportion to the vacancy centers a flexibility with a mayor”, Resaltó el direktor-generaal y cofundador de BioNTech, Ugur Sahin.

While acknowledging additional data regarding the stability of its vacancy, Pfizer and BioNTech are preventing the use of live vehicles and / or the “fecha de caducidad”you can amplify and be able to consider the possibility of placing the vaccine at an alternative temperature at short range”.

The first dose of the Pfizer vaccine is effective at 75% every week after administration

An Israeli hospital studio Skeba, defied this year and published in the scientific journal The Lancet, showed that the first dose of the vaccine produced by Pfizer 75% decrease in coronavirus infections at least once a week after his administration.

The study is one of the first in the world to analyze the efficacy of the first dose of Pfizer vaccine, which was based on a sample of more than 7,000 medical center workers in the study.

The results show a low efficacy of the first dose in the first two weeks of its administration per one high efficacy passed the first 14 days.

In addition to identifying a 75% reduction in the number of people contracting coronavirus, The study showed an 85% reduction in the number of people who witnessed COVID-19 symptoms.

Following the study, these dates allow you to conclude that it is possible to demarcate the administration of the second dose in pauses with evacuation of vacancies, in a way that more people can be inoculated.

Prohibition of probes, its authors acknowledge that it is necessary to carry out more tests, about all effects within the duration of effect of a single dose, before deciding whether a single dose policy is recommended.

“What our teachers say is that a significant level of evacuation can be considered, including a single dose”, explained the news agency EFE Arnon Afek, director of Sheba Hospital and one of the authors of the studio.

“Countries that need to evacuate large numbers of people and do not have the logistical capacity to administer such vacancies at the same time, as the United Kingdom decides to do so with a single dose and have a second mayor, vacancy rate indicating that this study brings scientific evidence to support its decision.

In accordance with the model used for this investigation, Afek admits that if the number of people is not particularly high, the students studied would be monitored in a constant and mitigating manner, even if it is possible that all work in the hospital lig diarios about its state of health in.

(More information on Europa Press and EFE)

MORE ABOUT THIS THEME:

United States rejects Chinese theory claiming to pandemic the import of congelada

United States contributes USD 4,000 million to the Covax World Vacation Program